How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation?

Journal of Cardiovascular Medicine

Volumn 11, Issue 10, 2010, Pages 727-732

  Saia, Francesco ^a   Marrozzini, Cinzia ^a   Dall'Ara, Gianni ^a   Russo, Vincenzo ^b   Martìn Suàrez, Sofia ^c   Savini, Carlo ^c   Ortolani, Paolo ^a   Palmerini, Tullio ^a   Taglieri, Nevio ^a   Bordoni, Barbara ^a   Pilato, Emanuele ^c   Di Bartolomeo, Roberto ^c   Branzi, Angelo ^a   Marzocchi, Antonio ^a  

^a Institute of Cardiology   (Italy)

^b Cardiovascular Radiology Unit   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Aortic valve stenosis; biologic prosthesis; cardiac surgery; percutaneous aortic balloon valvuloplasty; transcatheter

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; AORTA VALVE STENOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART SURGERY; HUMAN; MALE; MITRAL VALVE REGURGITATION; MORTALITY; PATIENT SELECTION; THORACIC AORTA; TRANSCATHETER AORTA VALVE IMPLANTATION; TRANSLUMINAL VALVULOPLASTY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BALLOON DILATION; ELIGIBILITY DETERMINATION; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; ITALY; MALE; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77956263821     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328338940f     Document Type: Article

References (23)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368:1005-1011.
2. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005; 26:2714-2720.
3. Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114:e84-e231.
4. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 2007; 28:230-268.
5. LiebermanEB, Bashore TM, Hermiller JB, Wilson JS, Pieper KS, Keeler GP, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol 1995; 26:1522-1528.
6. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106:3006-3008.
7. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006; 114:1616-1624.
8. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4:242-249.
9. Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006; 114:591-596.
10. Walther T, Falk V, Kempfert J, Borger MA, Fassl J, Chu MW, et al. Transapical minimally invasive aortic valve implantation: the initial 50 patients. Eur J Cardiothorac Surg 2008; 33:983-988.
11. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006; 82:2111-2115.
12. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J 1988; 9 (Suppl E):57-64.
13. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on valvular heart disease. Eur Heart J 2003; 24:1231-1243.
14. Bouma BJ, van Den Brink RB, van Der Meulen JH, Verheul HA, Cheriex EC, Hamer HP, et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 1999; 82:143-148.
15. Pai RG, Kapoor N, Bansal RC, Varadarajan P. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg 2006; 82:2116-2122.
16. Kolh P, Kerzmann A, Honore C, Comte L, Limet R. Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur J Cardiothorac Surg 2007; 31:600-606.
17. Chukwuemeka A, Rao V, Armstrong S, Ivanov J, David T. Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function. Eur J Cardiothorac Surg 2006; 29:133-138.
18. Kapadia SR, Goel SS, Svensson L, Roselli E, Savage RM, Wallace L, et al. Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J Thorac Cardiovasc Surg 2009; 137:1430-1435.
19. Otten AM, van Domburg RT, van Gameren M, Kappetein AP, Takkenberg JJ, Bogers AJ, et al. Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement. EuroIntervention 2008; 4:250-255.
20. Descoutures F, Himbert D, Lepage L, Iung B, Detaint D, Tchetche D, et al. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur Heart J 2008; 29:1410-1417.
21. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1986; 1:63-67.
22. Cribier A, Letac B. Percutaneous balloon aortic valvuloplasty in adults with calcific aortic stenosis. Curr Opin Cardiol 1991; 6:212-218.
23. Vahanian A. Balloon valvuloplasty. Heart 2001; 85:223-228.